Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Gainor, Justin F, Curigliano, Giuseppe, Kim, Dong-Wan, Lee, Dae Ho, Besse, Benjamin, Baik, Christina S, Doebele, Robert C, Cassier, Philippe A, Lopes, Gilberto, Tan, Daniel S W, Garralda, Elena, Paz-Ares, Luis G, Cho, Byoung Chul, Gadgeel, Shirish M, Thomas, Michael, Liu, Stephen V, Taylor, Matthew H, Mansfield, Aaron S, Zhu, Viola W, Clifford, Corinne, Zhang, Hui, Palmer, Michael, Green, Jennifer, Turner, Christopher D, Subbiah, Vivek
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Lee, Chung-Han, Shah, Amishi Yogesh, Rasco, Drew, Rao, Arpit, Taylor, Matthew H, Di Simone, Christopher, Hsieh, James J, Pinto, Alvaro, Shaffer, David R, Girones Sarrio, Regina, Cohn, Allen Lee, Vogelzang, Nicholas J, Bilen, Mehmet Asim, Gunnestad Ribe, Sara, Goksel, Musaberk, Tennøe, Øyvind Krohn, Richards, Donald, Sweis, Randy F, Courtright, Jay, Heinrich, Daniel, Jain, Sharad, Wu, Jane, Schmidt, Emmett V, Perini, Rodolfo F, Kubiak, Peter, Okpara, Chinyere E, Smith, Alan D, Motzer, Robert J
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
Hodi, F Stephen, Dr, Chesney, Jason, Prof, Pavlick, Anna C, MD, Robert, Caroline, Prof, Grossmann, Kenneth F, MD, McDermott, David F, MD, Linette, Gerald P, MD, Meyer, Nicolas, Prof, Giguere, Jeffrey K, MD, Agarwala, Sanjiv S, Prof, Shaheen, Montaser, MD, Ernstoff, Marc S, Prof, Minor, David R, MD, Salama, April K, MD, Taylor, Matthew H, MD, Ott, Patrick A, MD, Horak, Christine, PhD, Gagnier, Paul, MD, Jiang, Joel, PhD, Wolchok, Jedd D, Prof, Postow, Michael A, MD
Published in The lancet oncology (01.11.2016)
Published in The lancet oncology (01.11.2016)
Get full text
Journal Article
The ploidy conveyor of mature hepatocytes as a source of genetic variation
Duncan, Andrew W, Taylor, Matthew H, Hickey, Raymond D, Hanlon Newell, Amy E, Lenzi, Michelle L, Olson, Susan B, Finegold, Milton J, Grompe, Markus
Published in Nature (London) (07.10.2010)
Published in Nature (London) (07.10.2010)
Get full text
Journal Article
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer
Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J, Dutcus, Corina E, Song, James, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Capdevila, Jaume, Sherman, Steven I, Tahara, Makoto
Published in The journal of clinical endocrinology and metabolism (01.11.2016)
Published in The journal of clinical endocrinology and metabolism (01.11.2016)
Get full text
Journal Article
The LEAP program: lenvatinib plus pembrolizumab for the treatment of advanced solid tumors
Taylor, Matthew H, Schmidt, Emmett V, Dutcus, Corina, Pinheiro, Elaine M, Funahashi, Yasuhiro, Lubiniecki, Gregory, Rasco, Drew
Published in Future oncology (London, England) (01.02.2021)
Published in Future oncology (London, England) (01.02.2021)
Get full text
Journal Article
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
Motzer, Robert J., Taylor, Matthew H., Evans, Thomas R. Jeffry, Okusaka, Takuji, Glen, Hilary, Lubiniecki, Gregory M., Dutcus, Corina, Smith, Alan D., Okpara, Chinyere E., Hussein, Ziad, Hayato, Seiichi, Tamai, Toshiyuki, Makker, Vicky
Published in Expert review of anticancer therapy (03.04.2022)
Published in Expert review of anticancer therapy (03.04.2022)
Get full text
Journal Article
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
Apolo, Andrea B, Ellerton, John A, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael S, Aljumaily, Raid, Gourdin, Theodore, Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Manitz, Juliane, Pennock, Gregory, Ruisi, Mary, Gulley, James L, Patel, Manish R
Published in Journal for immunotherapy of cancer (01.10.2020)
Published in Journal for immunotherapy of cancer (01.10.2020)
Get full text
Journal Article
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Keilholz, Ulrich, Mehnert, Janice M, Bauer, Sebastian, Bourgeois, Hugues, Patel, Manish R, Gravenor, Donald, Nemunaitis, John J, Taylor, Matthew H, Wyrwicz, Lucjan, Lee, Keun-Wook, Kasturi, Vijay, Chin, Kevin, von Heydebreck, Anja, Gulley, James L
Published in Journal for immunotherapy of cancer (16.01.2019)
Published in Journal for immunotherapy of cancer (16.01.2019)
Get full text
Journal Article
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Mansfield, Aaron S., Hong, David S., Hann, Christine L., Farago, Anna F., Beltran, Himisha, Waqar, Saiama N., Hendifar, Andrew E., Anthony, Lowell B., Taylor, Matthew H., Bryce, Alan H., Tagawa, Scott T., Lewis, Karl, Niu, Jiaxin, Chung, Christine H., Cleary, James M., Rossi, Michael, Ludwig, Carrianne, Valenzuela, Ricardo, Luo, Yan, Aggarwal, Rahul
Published in NPJ precision oncology (05.08.2021)
Published in NPJ precision oncology (05.08.2021)
Get full text
Journal Article
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
Makker, Vicky, Taylor, Matthew H, Aghajanian, Carol, Cohn, Allen L, Brose, Marcia S, Simone, Christopher Di, Cao, Zhu Alexander, Suttner, Leah, Loboda, Andrey, Cristescu, Razvan, Jelinic, Petar, Orlowski, Robert, Dutta, Lea, Matsui, Junji, Dutcus, Corina E, Minoshima, Yukinori, Messing, Mark J
Published in Journal for immunotherapy of cancer (19.01.2024)
Published in Journal for immunotherapy of cancer (19.01.2024)
Get full text
Journal Article
Prediction of Thorough QT study results using action potential simulations based on ion channel screens
Mirams, Gary R., Davies, Mark R., Brough, Stephen J., Bridgland-Taylor, Matthew H., Cui, Yi, Gavaghan, David J., Abi-Gerges, Najah
Published in Journal of pharmacological and toxicological methods (01.11.2014)
Published in Journal of pharmacological and toxicological methods (01.11.2014)
Get full text
Journal Article
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
Callahan, Margaret, Amin, Asim, Kaye, Frederic J, Morse, Michael A, Taylor, Matthew H, Peltola, Katriina J, Sharma, Padmanee, O'Reilly, Eileen M, Meadows Shropshire, Stephanie, O'Brien, Shaun, Tschaika, Marina, Le, Dung T
Published in Journal for immunotherapy of cancer (05.02.2024)
Published in Journal for immunotherapy of cancer (05.02.2024)
Get full text
Journal Article
Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day
Taylor, Matthew H., Leboulleux, Sophie, Panaseykin, Yury, Konda, Bhavana, Fouchardiere, Christelle, Hughes, Brett G. M., Gianoukakis, Andrew G., Park, Young Joo, Romanov, Ilia, Krzyzanowska, Monika K., Garbinsky, Diana, Sherif, Bintu, Pan, Jie Janice, Binder, Terri A., Sauter, Nicholas, Xie, Ran, Brose, Marcia S.
Published in Cancer medicine (Malden, MA) (01.02.2023)
Published in Cancer medicine (Malden, MA) (01.02.2023)
Get full text
Journal Article
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
Gogas, Helen, Ravimohan, Shruthi, Datta, Antara, Chhibber, Aparna, Couselo, Eva Muñoz, Diab, Adi, Pereira, Caio, Quéreux, Gaëlle, Sandhu, Shahneen, Curti, Brendan, Khushalani, Nikhil I., Taylor, Matthew H., Daniels, Gregory A., Spreafico, Anna, Meniawy, Tarek, Van Den Eertwegh, Alfons J. M., Sun, Yongliang, Arriaga, Yull, Zhou, Ming, Long, Georgina V., Lebbé, Céleste
Published in NPJ precision oncology (19.07.2024)
Published in NPJ precision oncology (19.07.2024)
Get full text
Journal Article
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Makker, Vicky, Taylor, Matthew H, Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L, Romeo, Margarita, Bratos, Raquel, Brose, Marcia S, DiSimone, Christopher, Messing, Mark, Stepan, Daniel E, Dutcus, Corina E, Wu, Jane, Schmidt, Emmett V, Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Published in Journal of clinical oncology (10.09.2020)
Published in Journal of clinical oncology (10.09.2020)
Get full text
Journal Article
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
Taylor, Matthew H, Lee, Chung-Han, Makker, Vicky, Rasco, Drew, Dutcus, Corina E, Wu, Jane, Stepan, Daniel E, Shumaker, Robert C, Motzer, Robert J
Published in Journal of clinical oncology (10.04.2020)
Published in Journal of clinical oncology (10.04.2020)
Get full text
Journal Article
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Schlumberger, Martin, Tahara, Makoto, Wirth, Lori J, Robinson, Bruce, Brose, Marcia S, Elisei, Rossella, Habra, Mouhammed Amir, Newbold, Kate, Shah, Manisha H, Hoff, Ana O, Gianoukakis, Andrew G, Kiyota, Naomi, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Dutcus, Corina E, de las Heras, Begoña, Zhu, Junming, Sherman, Steven I
Published in The New England journal of medicine (12.02.2015)
Published in The New England journal of medicine (12.02.2015)
Get full text
Journal Article
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Weber, Jeffrey S, Carlino, Matteo S, Khattak, Adnan, Meniawy, Tarek, Ansstas, George, Taylor, Matthew H, Kim, Kevin B, McKean, Meredith, Long, Georgina V, Sullivan, Ryan J, Faries, Mark, Tran, Thuy T, Cowey, C Lance, Pecora, Andrew, Shaheen, Montaser, Segar, Jennifer, Medina, Theresa, Atkinson, Victoria, Gibney, Geoffrey T, Luke, Jason J, Thomas, Sajeve, Buchbinder, Elizabeth I, Healy, Jane A, Huang, Mo, Morrissey, Manju, Feldman, Igor, Sehgal, Vasudha, Robert-Tissot, Celine, Hou, Peijie, Zhu, Lili, Brown, Michelle, Aanur, Praveen, Meehan, Robert S, Zaks, Tal
Published in The Lancet (British edition) (17.02.2024)
Published in The Lancet (British edition) (17.02.2024)
Get full text
Journal Article
Prospective Prediction of Antitarget Activity by Matched Molecular Pairs Analysis
Warner, Daniel J., Bridgland-Taylor, Matthew H., Sefton, Clare E., Wood, David J.
Published in Molecular informatics (01.05.2012)
Published in Molecular informatics (01.05.2012)
Get full text
Journal Article